Hollywood Drug ‘Queen’ BUSTED – Sentenced 15 Years!

The woman who sold the ketamine that killed Matthew Perry walked into a federal courtroom expecting leniency and walked out with 15 years behind bars, a sentence that exposes the deadly pipeline feeding Hollywood’s addiction crisis.

Story Snapshot

Jasveen Sangha, known as the “Ketamine Queen,” received 15 years in federal prison for supplying the ketamine that killed actor Matthew Perry in October 2023
Sangha sold 25 vials of ketamine for $6,000 just four days before Perry’s death, continuing her drug operation despite knowing her supply had already contributed to at least one previous death
Federal prosecutors rejected her defense team’s request for time served, citing her complete lack of remorse and pattern of targeting wealthy Hollywood clients
Two additional defendants in Perry’s death, including his personal assistant Kenneth Iwamasa and middleman Erik Fleming, await sentencing and face up to 25 years in prison

The Hollywood Drug Dealer Who Kept Dealing After Death

Jasveen Sangha didn’t just sell drugs. She built a brand. Operating out of Los Angeles, she marketed herself as an exclusive supplier to Hollywood’s elite, earning the moniker “Ketamine Queen” among her wealthy clientele. Her business model relied on discretion, premium pricing, and a product pipeline that catered specifically to those who could afford her services. On October 24, 2023, she sold 25 vials of ketamine to representatives working for Matthew Perry for $6,000. Four days later, the beloved “Friends” actor was found dead in his Pacific Palisades hot tub.

What makes Sangha’s case particularly chilling isn’t just her role in Perry’s death. Federal prosecutors presented evidence that her ketamine supply had previously contributed to the 2019 death of Cody McLaury. Despite this knowledge, Sangha continued operating her distribution network without apparent concern for the consequences. This pattern of criminal behavior demonstrated to the court that she viewed human life as collateral damage in a profitable enterprise. The prosecution’s case painted a picture of calculated indifference, a drug dealer who understood the risks her product posed and chose profit over safety.

A Defense Strategy That Failed Spectacularly

Sangha’s attorneys attempted to secure leniency by highlighting her “exemplary behavior” as an inmate and requesting time served. Judge Sherilyn Peace Garnett rejected this argument entirely, following the prosecution’s recommendation for the maximum 15-year sentence. The judge’s message was clear: good behavior in custody doesn’t erase the deaths that put you there. Garnett told Sangha she would need to demonstrate “epic resilience” during her incarceration, a statement that underscored the severity of her crimes and the long road ahead.

The sentencing hearing included victim impact statements from Perry’s family, providing a human counterweight to the defense’s technical legal arguments. Federal prosecutors emphasized that Sangha showed no remorse for her actions, a factor that weighs heavily in sentencing decisions. Her continued drug dealing after learning of McLaury’s death revealed a fundamental disregard for human life that no amount of jailhouse compliance could offset. The justice system sent a message: if you profit from death and keep dealing, expect the full weight of consequences.

The Broader Network Faces Justice

Sangha represents just one piece of a larger criminal enterprise that facilitated Perry’s access to lethal doses of ketamine. Kenneth Iwamasa, Perry’s personal assistant, served as a critical middleman in the transaction, scheduled for sentencing on April 22, 2026, and facing up to 15 years. Erik Fleming, who coordinated sales between Sangha and Iwamasa, awaits sentencing on April 29, 2026, with exposure to 25 years in prison. The cascading prosecutions reveal how multiple individuals enabled Perry’s addiction, each playing a role in the supply chain that ultimately killed him.

This case establishes important precedent for holding drug suppliers accountable in celebrity overdose deaths. Too often, the focus remains on the victim’s choices while those who profited from addiction escape serious consequences. The federal government’s aggressive prosecution of everyone involved in Perry’s death signals a shift in approach. When wealthy individuals die from drug overdoses, investigators now pursue the entire distribution network, not just the end user. This comprehensive strategy acknowledges that addiction creates vulnerable victims, and those who exploit that vulnerability for profit bear criminal responsibility.

The “Ketamine Queen” case exposes uncomfortable truths about substance abuse in Hollywood and the predators who feed it. Sangha didn’t create Matthew Perry’s addiction, but she certainly profited from it, and when her product killed, she kept dealing. That 15-year sentence reflects not just one man’s death, but a pattern of callous indifference that turned human suffering into a business model. As the remaining defendants face their own reckonings, the message resonates beyond Los Angeles courtrooms: if you deal death to the desperate, justice will eventually find you.